NCT02984670

Brief Summary

The overall purpose with this investigation is to further our knowledge about cognitive behavioral therapy (CBT) for insomnia by examining treatment components, mediators, and moderators. The first aim that will be addressed is to explore the efficacy of the CBT components with a dismantling-treatment strategy. Two active CBT interventions, intended to define its components - cognitive therapy and behavior therapy - will be compared with one another as well as with a waitlist condition on a broad range of outcomes at five to nine assessment points depending on the measures. The design will thus enable us to examine what CBT component or components are necessary, sufficient and facilitative of therapeutic change. The second aim that will be explored is to investigate what processes occur in CBT that may contribute to treatment outcome with a treatment-mediator strategy. To examine mediators for CBT, the following mediators will be assessed; Anxiety and Preoccupation about sleep Questionnaire (APSQ), Dysfunctional Beliefs and Attitudes about Sleep (DBAS), Sleep Associated Monitoring Index (SAMI), Sleep-Related Behavior Questionnaire (SRBQ), time in bed, napping, bedtime variability, and rise time variability. The hypothesis is that cognitive processes will mediate cognitive therapy outcomes, and that behavioral factors will have a mediating role for behavior therapy improvements. The third aim that will be addressed is to examine what patient characteristics does CBT depend on to be effective with a treatment-moderator strategy. To investigate moderators for CBT, the following moderators will be assessed; age, gender, occupational status, level of education, initial insomnia severity, dysfunction, medication use, chronic pain, psychiatric co-morbidity, medical co-morbidity, behavioral and cognitive processes used as mediators will also be employed as moderators.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
219

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Aug 2016

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2016

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

November 21, 2016

Completed
16 days until next milestone

First Posted

Study publicly available on registry

December 7, 2016

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2017

Completed
Last Updated

April 19, 2018

Status Verified

April 1, 2018

Enrollment Period

1.3 years

First QC Date

November 21, 2016

Last Update Submit

April 17, 2018

Conditions

Keywords

Cognitive therapyBehavior therapyModerationMediation

Outcome Measures

Primary Outcomes (1)

  • Changes on the insomnia severity index (ISI).

    Pretreatment (week 0), during treatment (i.e., at week: 2, 4, 6, 8), post-treatment (week 10) and follow-up at 6, 12, and 18 month after treatment.

Secondary Outcomes (10)

  • Changes on the Work and Social Adjustment Scale (WSAS).

    Pretreatment (week 0), post-treatment (week 10) and follow-up at 6, 12, and 18 month after treatment.

  • Changes in sleep onset latency (SOL).

    Pretreatment (week 0), during treatment (week: 2, 4, 6, 8) and post-treatment (week 10).

  • Changes in wake time after sleep onset (WASO).

    Pretreatment (week 0), during treatment (week: 2, 4, 6, 8) and post-treatment (week 10).

  • Changes in early morning awakenings (EMA).

    Pretreatment (week 0), during treatment (week: 2, 4, 6, 8) and post-treatment (week 10).

  • Changes in total sleep time (TST).

    Pretreatment (week 0), during treatment (week: 2, 4, 6, 8) and post-treatment (week 10).

  • +5 more secondary outcomes

Other Outcomes (10)

  • Credibility Expectancy Questionnaire (CEQ ).

    During the first treatment module.

  • Client Satisfaction Questionnaire (CSQ-8).

    Post-treatment (week 10).

  • Activity and adherence with treatment protocol (self developed questionnaire assessing treatment activity and adherence relating to text, homework and therapist support).

    Post-treatment (week 10).

  • +7 more other outcomes

Study Arms (3)

Behavior Therapy

EXPERIMENTAL
Behavioral: Behavior Therapy

Cognitive Therapy

EXPERIMENTAL
Behavioral: Cognitive Therapy

Waitlist

OTHER
Behavioral: Waitlist.

Interventions

Cognitive Therapy involves challenging negative automatic thoughts about sleep and the use of behavioral experiments to challenge and test five cognitive processes (i.e., worry, dysfunctional thoughts, monitoring, safety behaviours, misperception) proposed to perpetuate insomnia.

Cognitive Therapy

Behavior Therapy involves the use of stimulus control and sleep restriction in order to reverse maladaptive sleep habits (time in bed, napping, bedtime variability, rise time variability) proposed to maintain insomnia. It also involves the practice of sleep hygiene principles.

Behavior Therapy
Waitlist.BEHAVIORAL

The waitlist serves as a passive control which will receive the same measures administered to the cognitive and behaviour therapy groups.

Waitlist

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Presence of insomnia more than three nights per week and for more than three months.
  • Insomnia despite adequate opportunity to sleep.
  • Insomnia severity typical for insomnia disorder, i.e. 11 points or more on the Insomnia Severity Index (ISI).
  • Nighttime insomnia symptoms, i.e., two points or more on at least one of the first three ISI questions.
  • Daytime insomnia symptoms, i.e. two points or more on one or both of the ISI distress and impairment items (numbers 5 and 7).
  • Clinical insomnia symptoms from sleep diaries concerning three nighttime symptoms (difficulties with sleep initiation, difficulties with sleep maintenance, and early morning awakenings), i.e., thirty minutes or more on average on one or more of the symptoms.
  • No current or past CBT-I treatment within the past 5 years.
  • Time and opportunity to participate in treatment for ten weeks.
  • Time and opportunity to read approximately fifteen pages per week and execute homework assignments for ten weeks.
  • Access to a computer, email and internet.

You may not qualify if:

  • Severe depression, i.e., more than 30 points on MADRS-S.
  • Suicidal risk, i.e., 4 points or more on item 9 on MADRS-S.
  • A high intake of alcohol or caffeine,
  • Insomnia due to shiftwork or other sleep-disturbing events (e.g., pregnancy, small children, or animals in the sleep environment).
  • Participants with a history of psychotic or bipolar disorder.
  • If a somatic condition is reported, it is required that it is relatively stable and/or that the candidate is receiving treatment for the condition.
  • When a candidate fulfills criteria for a psychiatric or somatic condition, it is required that insomnia is the disorder currently most distressing and disabling or that the insomnia remains despite treatment for the comorbid condition.
  • Participants with the following primary sleep disorders will be excluded via the Duke Structured Interview for Sleep Disorders (DSISD): sleep apnea, restless legs syndrome, periodic limb movement disorder, circadian rhythm disorder, and parasomnias.
  • If sleep medication is used, it is required that the use has been relatively stable during three months.
  • If Selective Serotonin Reuptake Inhibitors (SSRI) use is reported, it is required that the onset of the medication was at least three months prior to the telephone interview.
  • Participants who regularly consume sleep-disturbing medications.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Stockholm University

Stockholm, Sweden

Location

Related Publications (3)

  • Sunnhed R, Hesser H, Andersson G, Carlbring P, Lindner P, Harvey AG, Jansson-Frojmark M. Mediators of cognitive therapy and behavior therapy for insomnia disorder: A test of the processes in the cognitive model. J Consult Clin Psychol. 2022 Sep;90(9):696-708. doi: 10.1037/ccp0000756. Epub 2022 Sep 8.

  • Blanken TF, Jansson-Frojmark M, Sunnhed R, Lancee J. Symptom-specific effects of cognitive therapy and behavior therapy for insomnia: A network intervention analysis. J Consult Clin Psychol. 2021 Apr;89(4):364-370. doi: 10.1037/ccp0000625. Epub 2021 Feb 25.

  • Sunnhed R, Hesser H, Andersson G, Carlbring P, Morin CM, Harvey AG, Jansson-Frojmark M. Comparing internet-delivered cognitive therapy and behavior therapy with telephone support for insomnia disorder: a randomized controlled trial. Sleep. 2020 Feb 13;43(2):zsz245. doi: 10.1093/sleep/zsz245.

Related Links

MeSH Terms

Conditions

Sleep Initiation and Maintenance DisordersNegotiating

Interventions

Cognitive Behavioral TherapyBehavior TherapyWaiting Lists

Condition Hierarchy (Ancestors)

Sleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental DisordersCommunicationBehavior

Intervention Hierarchy (Ancestors)

PsychotherapyBehavioral Disciplines and ActivitiesAppointments and SchedulesOrganization and AdministrationHealth Services Administration

Study Officials

  • Markus Jansson Fröjmark, PhD

    Karolinska Institutet

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PhD.

Study Record Dates

First Submitted

November 21, 2016

First Posted

December 7, 2016

Study Start

August 1, 2016

Primary Completion

November 1, 2017

Study Completion

November 1, 2017

Last Updated

April 19, 2018

Record last verified: 2018-04

Data Sharing

IPD Sharing
Will not share

Locations